381 related articles for article (PubMed ID: 18490064)
1. Early detection of memory deficits and memory improvement with vaccinia virus complement control protein in an Alzheimer's disease model.
Pillay NS; Kellaway LA; Kotwal GJ
Behav Brain Res; 2008 Oct; 192(2):173-7. PubMed ID: 18490064
[TBL] [Abstract][Full Text] [Related]
2. Intracranial administration of vaccinia virus complement control protein in Mo/Hu APPswe PS1dE9 transgenic mice at an early age shows enhanced performance at a later age using a cheese board maze test.
Kulkarni AP; Pillay NS; Kellaway LA; Kotwal GJ
Biogerontology; 2008 Dec; 9(6):405-20. PubMed ID: 18679819
[TBL] [Abstract][Full Text] [Related]
3. Visuo-spatial learning and memory deficits on the Barnes maze in the 16-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
O'Leary TP; Brown RE
Behav Brain Res; 2009 Jul; 201(1):120-7. PubMed ID: 19428625
[TBL] [Abstract][Full Text] [Related]
4. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.
Savonenko A; Xu GM; Melnikova T; Morton JL; Gonzales V; Wong MP; Price DL; Tang F; Markowska AL; Borchelt DR
Neurobiol Dis; 2005 Apr; 18(3):602-17. PubMed ID: 15755686
[TBL] [Abstract][Full Text] [Related]
5. Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern.
Melnikova T; Savonenko A; Wang Q; Liang X; Hand T; Wu L; Kaufmann WE; Vehmas A; Andreasson KI
Neuroscience; 2006 Sep; 141(3):1149-62. PubMed ID: 16753269
[TBL] [Abstract][Full Text] [Related]
6. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
[TBL] [Abstract][Full Text] [Related]
7. Effects of progesterone administration and APPswe+PSEN1Deltae9 mutation for cognitive performance of mid-aged mice.
Frye CA; Walf AA
Neurobiol Learn Mem; 2008 Jan; 89(1):17-26. PubMed ID: 17988898
[TBL] [Abstract][Full Text] [Related]
8. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.
Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS
J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767
[TBL] [Abstract][Full Text] [Related]
9. Estrogen treatment improves spatial learning in APP + PS1 mice but does not affect beta amyloid accumulation and plaque formation.
Heikkinen T; Kalesnykas G; Rissanen A; Tapiola T; Iivonen S; Wang J; Chaudhuri J; Tanila H; Miettinen R; Puoliväli J
Exp Neurol; 2004 May; 187(1):105-17. PubMed ID: 15081593
[TBL] [Abstract][Full Text] [Related]
10. Aspects of spatial memory and behavioral disinhibition in Tg2576 transgenic mice as a model of Alzheimer's disease.
Ognibene E; Middei S; Daniele S; Adriani W; Ghirardi O; Caprioli A; Laviola G
Behav Brain Res; 2005 Jan; 156(2):225-32. PubMed ID: 15582108
[TBL] [Abstract][Full Text] [Related]
11. Levodopa ameliorates learning and memory deficits in a murine model of Alzheimer's disease.
Ambrée O; Richter H; Sachser N; Lewejohann L; Dere E; de Souza Silva MA; Herring A; Keyvani K; Paulus W; Schäbitz WR
Neurobiol Aging; 2009 Aug; 30(8):1192-204. PubMed ID: 18079024
[TBL] [Abstract][Full Text] [Related]
12. Impaired spatial learning in the APPSwe + PSEN1DeltaE9 bigenic mouse model of Alzheimer's disease.
Reiserer RS; Harrison FE; Syverud DC; McDonald MP
Genes Brain Behav; 2007 Feb; 6(1):54-65. PubMed ID: 17233641
[TBL] [Abstract][Full Text] [Related]
13. Working memory impairment in a transgenic amyloid precursor protein TgCRND8 mouse model of Alzheimer's disease.
Lovasic L; Bauschke H; Janus C
Genes Brain Behav; 2005 Apr; 4(3):197-208. PubMed ID: 15810906
[TBL] [Abstract][Full Text] [Related]
14. Induced LC degeneration in APP/PS1 transgenic mice accelerates early cerebral amyloidosis and cognitive deficits.
Jardanhazi-Kurutz D; Kummer MP; Terwel D; Vogel K; Dyrks T; Thiele A; Heneka MT
Neurochem Int; 2010 Nov; 57(4):375-82. PubMed ID: 20144675
[TBL] [Abstract][Full Text] [Related]
15. A detailed analysis of the early context extinction deficits seen in APPswe/PS1dE9 female mice and their relevance to preclinical Alzheimer's disease.
Bonardi C; de Pulford F; Jennings D; Pardon MC
Behav Brain Res; 2011 Sep; 222(1):89-97. PubMed ID: 21440575
[TBL] [Abstract][Full Text] [Related]
16. Age-related changes in visual acuity, learning and memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
Stover KR; Brown RE
Behav Brain Res; 2012 May; 231(1):75-85. PubMed ID: 22409975
[TBL] [Abstract][Full Text] [Related]
17. Targeted introduction of V642I mutation in amyloid precursor protein gene causes functional abnormality resembling early stage of Alzheimer's disease in aged mice.
Kawasumi M; Chiba T; Yamada M; Miyamae-Kaneko M; Matsuoka M; Nakahara J; Tomita T; Iwatsubo T; Kato S; Aiso S; Nishimoto I; Kouyama K
Eur J Neurosci; 2004 May; 19(10):2826-38. PubMed ID: 15147316
[TBL] [Abstract][Full Text] [Related]
18. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
Arendash GW; Schleif W; Rezai-Zadeh K; Jackson EK; Zacharia LC; Cracchiolo JR; Shippy D; Tan J
Neuroscience; 2006 Nov; 142(4):941-52. PubMed ID: 16938404
[TBL] [Abstract][Full Text] [Related]
19. Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1DeltaE9 mouse model of Alzheimer's disease.
Toledo EM; Inestrosa NC
Mol Psychiatry; 2010 Mar; 15(3):272-85, 228. PubMed ID: 19621015
[TBL] [Abstract][Full Text] [Related]
20. Age-related cognitive decline and nesting behavior in an APPswe/PS1 bigenic model of Alzheimer's disease.
Filali M; Lalonde R
Brain Res; 2009 Oct; 1292():93-9. PubMed ID: 19643098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
